arrow
A

Andrea Carugno

University of Insubria
H指数:28
被引数:1.3万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Combination therapies for hidradenitis suppurativa: Narrative review of current strategies and emerging perspectives

Hidradenitis suppurativa的组合疗法:当前策略与新兴视角的叙述性综述

2026-05-200
PRE
Dissecting the Spectrum of Rare BRAF Mutations in Melanoma: A Nation-Wide Study by the Italian Melanoma Intergroup (IMI)

解析黑色素瘤中罕见BRAF突变的谱系:意大利黑色素瘤协作组(IMI)开展的一项全国性研究

2026-04-190
OAAI
Dupilumab for Prurigo Nodularis: Real-World Outcomes Up to 104 Weeks from the DUPItaPN Study

度普利尤单抗治疗结节性痒疹:DUPItaPN研究104周真实世界结局

2026-04-150
OA
Assessment of Safety and Tissue Integration of PEGDE-Based Hyaluronic Acid Filler for Severe Nasolabial Folds: A Prospective Observational Study with Biophysical and Ultrasound Evaluation

评估PEGDE基透明质酸填充剂用于严重鼻唇沟纹的安全性及组织相容性:一项结合生物物理学和超声评估的前瞻性观察研究

2026-03-040
OAAI
Psoriasis and seronegative spondyloarthropathy in patients with atopic dermatitis treated with dupilumab or tralokinumab: a multicentre observational study

特应性皮炎患者接受度普利尤单抗或特拉利尤单抗治疗时的银屑病和血清阴性脊柱关节病:一项多中心观察性研究

2026-02-011
PRE
Addiction and chronic skin diseases: A Pan-European study on prevalence, associations and patient impact

成瘾与慢性皮肤疾病:一项关于患病率、关联因素及患者影响的泛欧洲研究

2025-12-140
OAAI
Intraclass switching of interleukin-23 inhibitors in psoriasis: effectiveness, patterns and predictors of response - a retrospective multicentre study in Italy

IL-23抑制剂在银屑病中的类内转换:有效性、模式和应答预测因子——一项意大利多中心回顾性研究

2025-12-010
PRE
Tirbanibulin 1% real-world use in 679 actinic keratoses patients during warm season (SUMM-AK study)

Tirbanibulin 1%在温暖季节(SUMM-AK研究)中679例光线性角化病患者中的真实世界应用

2025-11-260
OAAI
Cumulative clinical benefits of biologic treatments in patients with moderate-to-severe psoriasis: an Italian real-life experience - IL PSO (Italian Landscape Psoriasis)

中度至重度银屑病患者生物制剂治疗的累积临床获益:一项意大利真实世界经验 - IL PSO(意大利银屑病全景)

2025-11-010
PRE
Long-Term Treatment With Systemic Rifampicin and Clindamycin for Epidermal Growth Factor Receptor Inhibitor-Related Acneiform and Mucocutaneous Rash: A Valid Therapeutic Option

长期系统性使用利福平和克林霉素治疗表皮生长因子受体抑制剂相关的痤疮样和黏膜皮肤疹:一种有效的治疗选择

2025-10-290
PRE
Brodalumab Efficacy in Psoriasis Patients with Inadequate Response to IL-23 or IL-12/23 Inhibitors: Multicenter Italian Retrospective Analysis-IL PSO (Italian Landscape Psoriasis)

Brodalumab在对抗IL-23或IL-12/23抑制剂反应不足的银屑病患者中的疗效:多中心意大利回顾性分析-IL PSO(意大利银屑病全景)

2025-10-010
OAAI
Safety and Effectiveness of Dupilumab in Atopic Dermatitis Patients with Hematologic Comorbidities: A Multicenter, Retrospective Study

Dupilumab在伴有血液学合并症的特应性皮炎患者中的安全性与有效性:一项多中心、回顾性研究

2025-09-080
OA